Further clinical analysis reveals that Fra1 is positively correlated with β-catenin and glioma progression, which confirms a critical role of Wnt/β-catenin/Fra1 signalling axis in glioma aggressiveness. This evidence concerns the gene FOSL1 and central nervous system cancer.